Phillips, Roger M., Pearce, J., Loadman, Paul M., Bibby, M.C., Cooper, P.A., Swaine, D.J. and Double, J.A. (1998) Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs. Cancer Research, 58 (23). pp. 5263-5266. ISSN 0008-5472Metadata only available from this repository.
The National Cancer Institute uses the hollow fiber assay as part of its screening program for anticancer drug discovery. Angiogenesis to hollow fibers implanted s.c. has not been reported, thereby raising concerns about the efficiency of drug delivery and its subsequent effects on chemosensitivity. By extending postimplantation times beyond the 6-day period presently used, extensive vascular networks develop, resulting in both increased delivery and chemosensitivity to doxorubicin. This study suggests that present protocols used to evaluate compounds may produce false negative results, and additional studies to determine the predictive value of the assay are required.
|Subjects:||R Medicine > RM Therapeutics. Pharmacology|
|Schools:||School of Applied Sciences|
|Depositing User:||Roger Phillips|
|Date Deposited:||13 May 2015 13:55|
|Last Modified:||13 May 2015 13:55|
Downloads per month over past year
Repository Staff Only: item control page